Information Provided By:
Fly News Breaks for December 17, 2015
ROSG
Dec 17, 2015 | 17:00 EDT
Cantor Fitzgerald analyst Bryan Brokmeier initiated Rosetta Genomics with a Speculative Buy rating and a fair value of $3-$5.
News For ROSG From the Last 2 Days
There are no results for your query ROSG